Delivery Order SPE2DB25D3306-SPE2DB25FUCMU
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,385.52 to AmerisourceBergen Drug Corp for 30 tablets of Orgovyx 120 mg, a pharmaceutical product used in the treatment of prostate cancer. This non-competitive, firm fixed-price delivery order was issued on October 20, 2025, with completion required by November 10, 2025. The product will be delivered to AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for 30 tablets of Orgovyx 120 mg, a pharmaceutical product used in prostate cancer treatment, with a contract ceiling value of $1,385.52. The award was competitively procured without set-aside designation and carries a firm fixed price structure, with an ultimate completion date of June 3, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 30 tablets of Orgovyx 120 mg, a pharmaceutical product used in prostate cancer treatment. This non-set-aside, firm fixed-price delivery order is valued at $2,771.04 with an ultimate completion date of May 12, 2025. The award was announced on April 21, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,385.52 to AmerisourceBergen Drug Corp for 30 tablets of Orgovyx 120 mg on August 19, 2025, with an ultimate completion date of September 10, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Orgovyx is a prescription medication used in the treatment of prostate cancer, reflecting the...
- The Defense Logistics Agency awarded a delivery order valued at $2,771.04 to AmerisourceBergen Drug Corp for 30 tablets of Orgovyx 120 mg, a prescription medication used in the treatment of prostate cancer. The contract is a firm fixed price delivery order with an ultimate completion date of August 8, 2025, and was competitively awarded without set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform fulfillment from its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $2,771.04 to AmerisourceBergen Drug Corp for 30 units of Orgovyx 120 mg tablets, a pharmaceutical product used in hormone-based cancer treatment. Issued on July 21, 2025, with an ultimate completion date of August 11, 2025, this firm fixed-price delivery order represents a routine pharmaceutical supply transaction under a competitive, non-set-aside procurement. The work will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $5,542.08 to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets (30-count units) on August 28, 2025, with completion scheduled for September 19, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Orgovyx is a specialized pharmaceutical used in the treatment of prostate...
- The Defense Logistics Agency awarded a $1,385.52 delivery order to AmerisourceBergen Drug Corp for 30 tablets of Orgovyx 120 mg on September 24, 2025, with an ultimate completion date of October 16, 2025. This firm fixed price, competitively awarded contract represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply relationship with DLA. The contract specifies performance at the vendor's corporate office location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $24,939.36 to AmerisourceBergen Drug Corp for 30-unit supplies of Orgovyx 120 mg tablets, with an ultimate completion date of August 26, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a potential value of $999,999,999.00 through December 2026. The place of performance is located...
- The Defense Logistics Agency awarded a competitive, firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units. The contract ceiling value is $1,385.52, with an ultimate completion date of September 10, 2025. This delivery order represents a child contract executed under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and...
- SPE2DB25D3306Indefinite Delivery Contract
- SPE2DB25D3306-SPE2DB25FUCMUDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 30 tablets of Orgovyx 120 mg, a pharmaceutical product used in hormone therapy for prostate cancer treatment. This competitively awarded, firm fixed-price delivery order has a ceiling value of $1,385.52 and is scheduled for completion by August 25, 2025. The contract was issued on August 4, 2025, with no set-aside designation, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime IDC serves as a comprehensive global pharmaceutical supply vehicle enabling AmerisourceBergen to furnish a broad range of medications and medical supplies to support military healthcare programs worldwide. The contract supports critical medical needs across multiple therapeutic domains for customers including the Defense Health Agency and U.S. Coast Guard, positioning AmerisourceBergen as a key pharmaceutical distributor within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 8/4/25 |